Celldex Therapeutics Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bullish stance on Celldex Therapeutics.

Looking at options history for Celldex Therapeutics CLDX we detected 10 strange trades.

If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.

From the overall spotted trades, 6 are puts, for a total amount of $192,989 and 4, calls, for a total amount of $179,327.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $22.5 to $25.0 for Celldex Therapeutics over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Celldex Therapeutics's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celldex Therapeutics's whale activity within a strike price range from $22.5 to $25.0 in the last 30 days.

Celldex Therapeutics Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
CLDX CALL SWEEP BEARISH 11/17/23 $25.00 $52.7K 104 105
CLDX CALL SWEEP BEARISH 11/17/23 $22.50 $45.8K 20 329
CLDX CALL SWEEP BEARISH 11/17/23 $22.50 $43.5K 20 10
CLDX PUT SWEEP BULLISH 11/17/23 $22.50 $41.3K 1.0K 672
CLDX CALL TRADE BULLISH 01/19/24 $25.00 $37.1K 96 3

Ready to win big? Discover the #1 strategy for trading options in today's unpredictable market... with potential gains of 44%, 125% and even 411% every month on average. Starting at only $1 a day. Click here now.

Where Is Celldex Therapeutics Standing Right Now?

  • With a volume of 602,165, the price of CLDX is up 5.69% at $24.91.
  • RSI indicators hint that the underlying stock may be approaching oversold.
  • Next earnings are expected to be released in 11 days.

What The Experts Say On Celldex Therapeutics:

  • Cantor Fitzgerald downgraded its action to Overweight with a price target of $54

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Celldex Therapeutics, Benzinga Pro gives you real-time options trades alerts.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date of Trade
▲▼
ticker
▲▼
Put/Call
▲▼
Strike Price
▲▼
DTE
▲▼
Sentiment
▲▼
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!